News posted by www.newsinfoline.com
Mumbai, July 6 (PTI) Swedish drugmaker AstraZeneca Pharmaceuticals AB today fixed the floor price for the delisting of its Indian arm at Rs 576.10 a share. In a filing to the Bombay Stock Exchange, AstraZeneca Pharma India -- the Indian arm of the Swedish pharma major, said Pharmaceuticals AB has approved the floor price of Rs 576.10 per share for the delisting offer following a valuation report by its chartered accountants -- Walker, Chandiok & Co. On June 29, Sweden-based Astra Pharmaceuticals AB had come out with a voluntary delisting offer for the shareholders of its Indian arm, AstraZeneca. Since then the stock has shot up nearly 11 per cent to Rs 1,335.10 on the BSE at the end of the trade today. The decision comes close on the heels of the government''s move to make it mandatory for all listed companies to raise public shareholding to a minimum of 25 per cent. Sweden-based AstraZeneca Pharmaceuticals AB holds 89.99 per cent stake in AstraZeneca Pharma India.
News posted by www.newsinfoline.com
Click here to read more news from www.newsinfoline.com
Please follow our blogs
newsinfolinephotogallery
prabugallery
newsinfolinephotogallery1
photogallery1
No comments:
Post a Comment